Ubs Group Ag Biomarin Pharmaceutical Inc Transaction History

Ubs Group Ag

  • $555 Billion
  • Q2 2025

A detailed history of Ubs Group Ag transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Ubs Group Ag holds 1,695,593 shares of BMRN stock, worth $94 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
1,695,593
Previous 1,694,014 0.09%
Holding current value
$94 Million
Previous $120 Million 22.17%
% of portfolio
0.02%
Previous 0.02%

Shares

34 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025
BUY
$54.08 - $68.32 $85,392 - $107,877
1,579 Added 0.09%
1,695,593 $93.2 Million
Q1 2025

May 13, 2025
BUY
$61.25 - $72.83 $11.4 Million - $13.5 Million
185,381 Added 12.29%
1,694,014 $120 Million
Q4 2024

Feb 14, 2025
BUY
$61.93 - $70.49 $40 Million - $45.6 Million
646,662 Added 75.02%
1,508,633 $99.2 Million
Q3 2024

Nov 14, 2024
BUY
$69.02 - $93.84 $32.9 Million - $44.7 Million
476,429 Added 123.57%
861,971 $60.6 Million
Q2 2024

Aug 13, 2024
SELL
$74.43 - $92.22 $348 Million - $431 Million
-4,670,897 Reduced 92.38%
385,542 $31.7 Million
Q1 2024

May 13, 2024
BUY
$83.81 - $99.0 $416 Million - $491 Million
4,963,987 Added 5369.26%
5,056,439 $442 Million
Q4 2023

Feb 09, 2024
SELL
$76.22 - $98.51 $11.6 Million - $15.1 Million
-152,805 Reduced 62.3%
92,452 $8.91 Million
Q3 2023

Nov 09, 2023
SELL
$85.07 - $94.48 $2.1 Million - $2.34 Million
-24,719 Reduced 9.16%
245,257 $21.7 Million
Q2 2023

Aug 11, 2023
BUY
$86.68 - $100.3 $6.45 Million - $7.47 Million
74,431 Added 38.06%
269,976 $23.4 Million
Q1 2023

May 12, 2023
SELL
$87.74 - $117.27 $41.4 Million - $55.3 Million
-471,739 Reduced 70.7%
195,545 $19 Million
Q4 2022

Feb 08, 2023
SELL
$80.93 - $108.63 $35.4 Million - $47.6 Million
-437,947 Reduced 39.62%
667,284 $69.1 Million
Q3 2022

Nov 10, 2022
SELL
$82.16 - $96.94 $130 Million - $154 Million
-1,588,293 Reduced 58.97%
1,105,231 $93.7 Million
Q2 2022

Aug 10, 2022
SELL
$71.48 - $86.85 $12 Million - $14.6 Million
-167,979 Reduced 5.87%
2,693,524 $223 Million
Q1 2022

May 16, 2022
BUY
$74.28 - $92.69 $200 Million - $250 Million
2,697,524 Added 1645.04%
2,861,503 $221 Million
Q4 2021

Feb 14, 2022
SELL
$71.72 - $91.47 $9.58 Million - $12.2 Million
-133,514 Reduced 44.88%
163,979 $14.5 Million
Q3 2021

Nov 15, 2021
BUY
$74.77 - $85.47 $11.5 Million - $13.1 Million
153,667 Added 106.84%
297,493 $23 Million
Q2 2021

Aug 13, 2021
SELL
$75.51 - $84.79 $3.89 Million - $4.37 Million
-51,512 Reduced 26.37%
143,826 $12 Million
Q1 2021

May 12, 2021
BUY
$74.73 - $90.69 $4.88 Million - $5.92 Million
65,250 Added 50.16%
195,338 $14.8 Million
Q4 2020

Feb 11, 2021
BUY
$72.61 - $90.2 $3.31 Million - $4.12 Million
45,648 Added 54.06%
130,088 $11.4 Million
Q3 2020

Nov 12, 2020
SELL
$71.87 - $131.03 $2.89 Million - $5.27 Million
-40,207 Reduced 32.26%
84,440 $6.42 Million
Q2 2020

Jul 31, 2020
BUY
$79.55 - $124.22 $530,916 - $829,044
6,674 Added 5.66%
124,647 $15.4 Million
Q1 2020

May 01, 2020
SELL
$71.37 - $96.85 $1.88 Million - $2.55 Million
-26,296 Reduced 18.23%
117,973 $9.97 Million
Q4 2019

Feb 14, 2020
SELL
$64.27 - $86.37 $9.89 Million - $13.3 Million
-153,846 Reduced 51.61%
144,269 $12.2 Million
Q3 2019

Nov 14, 2019
BUY
$67.4 - $85.11 $10.1 Million - $12.7 Million
149,236 Added 100.24%
298,115 $20.1 Million
Q2 2019

Aug 14, 2019
SELL
$80.35 - $93.9 $1.55 Million - $1.82 Million
-19,346 Reduced 11.5%
148,879 $12.8 Million
Q1 2019

May 14, 2019
BUY
$84.2 - $98.62 $762,346 - $892,905
9,054 Added 5.69%
168,225 $14.9 Million
Q4 2018

Feb 14, 2019
SELL
$80.14 - $106.07 $933,550 - $1.24 Million
-11,649 Reduced 6.82%
159,171 $13.6 Million
Q3 2018

Nov 14, 2018
BUY
$93.92 - $105.72 $5.21 Million - $5.86 Million
55,475 Added 48.09%
170,820 $16.6 Million
Q2 2018

Aug 14, 2018
SELL
$76.01 - $99.03 $9.82 Million - $12.8 Million
-129,186 Reduced 52.83%
115,345 $10.9 Million
Q1 2018

May 15, 2018
BUY
$77.67 - $92.63 $4.98 Million - $5.94 Million
64,143 Added 35.56%
244,531 $19.8 Million
Q4 2017

Feb 14, 2018
BUY
$80.76 - $95.13 $2 Million - $2.36 Million
24,825 Added 15.96%
180,388 $16.1 Million
Q3 2017

Nov 14, 2017
SELL
$80.6 - $94.95 $1.97 Million - $2.32 Million
-24,469 Reduced 13.59%
155,563 $14.5 Million
Q2 2017

Aug 14, 2017
BUY
N/A
20,636 Added 12.95%
180,032 $16.4 Million
Q1 2017

Nov 14, 2017
BUY
N/A
159,396
159,396 $14 Million

Others Institutions Holding BMRN

# of Institutions
674
Shares Held
185M
Call Options Held
1.31M
Put Options Held
1.1M
View Full List

About BIOMARIN PHARMACEUTICAL INC

BMRN Quotes by TradingView
  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $10.3B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email